Parabilis Medicines, Inc.

Direct answer

Parabilis Medicines, Inc. is publicly traded on NASDAQ under the ticker PBLS.

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Can you invest in Parabilis Medicines, Inc.?

Yes. Parabilis Medicines, Inc. is publicly traded on NASDAQ under the ticker PBLS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Parabilis Medicines, Inc.

Detailed equity research is provided by MarketSnap.